SmartPill of Buffalo, NY, reported that clinical trials of its SmartPill capsule, a noninvasive ingestible medical device that captures biomedical data from within a patient's GI tract, will begin this month at the University of Louisville in Louisville, KY, bringing to five the number of sites participating in the company's clinical trials.
Twenty subjects, including 14 who are healthy and six who have been documented with gastroparesis, are expected to participate in the study, the company said. The primary objective is to demonstrate the correlation between the gastric residence times measured by the SmartPill ACT-I capsule and conventional scintigraphy, according to the Buffalo, NY-based firm.
By AuntMinnie.com staff writers
May 13, 2005
Related Reading
SmartPill adds clinical trial site, April 26, 2005
SmartPill begins clinical trials, April 12, 2005
Copyright © 2005 AuntMinnie.com
